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ABSTRACT
Objectives: To quantify the change in risk of central
line associated blood stream infection (CLABSI)
following the introduction of a closed infusion
container in intensive care units (ICUs) in two Latin
American cities.
Design: A state-space model was used to describe the
ﬂow of admissions through the ICU. This approach
correctly treats infection as a time-dependent
covariate.
Results: A closed system reduced the risk of CLABSI.
The hazard ratios for the closed versus open container
were between 0.15 and 0.31 (p values<0.001),
indicating a clinically signiﬁcant reduction in the risk of
admissions having a CLABSI. A simulation study
showed that a closed system reduced the number of
infections, costs and deaths.
Conclusions: The data reveal costs are saved and
health beneﬁts gained from fewer cases of CLABSI
after adoption of a closed infusion system. Information
is required on the costs of implementing the closed
system widely in these settings.
INTRODUCTION
Decisions on how to reduce healthcare
acquired infection (HAI) should be
informed by reliable data and appropriate
analyses. Novel infection control interven-
tions tend to increase costs, but cost savings
may result from avoided HAIs because treat-
ment and diagnosis costs are saved and
lengths of stay in hospital are shortened.
There are also health beneﬁts if cases of
infection are prevented and excess morbidity
and mortality risk reduced. Economic anal-
yses quantify these changes and provide
signals for decision makers.
Little is known about the economics of
reducing the risks of HAI in high income
countries
1 2 where rates of HAI are relatively
low. Even less is known about the economics
of prevention in middle income settings
where rates are relatively high.
3e8 The aim of
this paper is to identify reductions in the risk
of central line associated blood stream infec-
tions (CLABSI) following the implementa-
tion of closed infusion containers among
admissions to intensive care units (ICUs) in
Brazil and Mexico. Analysis of the number of
bed days used and deaths occurring under an
open and closed infusion container system
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ARTICLE SUMMARY
Article focus
- The risks of central line associated blood stream
infections among patients in intensive care units
(ICUs) in Mexico and Sa ˜o Paulo were examined.
- Risks before and after the introduction of closed
infusion containers were compared.
- Simulation studies revealed the impact of the
change on the amount of bed days and number
of deaths.
Key messages
- Risks were reduced in both cities after the
introduction of closed infusion containers and
there was a statistically signiﬁcant reduction in
the number of deaths in both cities.
- A large reduction in bed days was observed in
Sa ˜o Paulo but not in Mexico.
- Closed instead of open infusion systems among
ICU patients reduces the risks of central line
associated blood stream infections, decreases
costs and saves lives.
Strengths and limitations of this study
- The fact that observational data were used and
other factors may explain the observed reduc-
tions in risk. Information on the cost of adopting
the closed system was not available but is
required to complete the economic argument.
The time-dependent covariate of infection was
correctly modelled by a state based method;
failure to account for timing of infection is an
important source of bias. There are few
published data on the value of improving
infection control in middle income settings
where the problem is relatively large and the
potential gains substantial.
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Open Access Researchamong ICU admissions will provide useful information
for infection control decision makers.
METHODS
Data collection
In this study we used data from ICUs in Brazil and
Mexico that were part of the International Nosocomial
Infection Control Consortium (INICC).
1 This is a quality
improving activity and this use of the data is exempt
from ethics or IRB review. The laboratory techniques
used, training programs for data collectors, deﬁnitions
of infection and surveillance activities are described in
detail by Rosenthal et al.
1 For this analysis, values for the
following variables were available: hospital name and
location; dates of admission, discharge and death; type
and site of HAI; average severity of illness score (ASIS);
and age. Data were also available that described time
periods, including a lead-in period, before and after the
introduction of a closed infusion system. Only data from
admissions with a central line are included.
Closed infusion container
The aim was to examine the effect of a closed versus
open infusion container on admissions requiring
a central line. The open container uses a glass or semi-
rigid plastic bottle or a burette that is open to the air in
order to allow the ﬂuid to exit.
2 The closed infusion
container uses a collapsible plastic bag with no external
venting. The ﬂuid in the closed infusion container is
protected from any airborne microorganism present in
the ICU. Closed infusion containers are standard
throughout North America and Western Europe.
Statistical methods
We used the state-space model shown in ﬁgure 1 to
model the ﬂow of admissions through the ICU, and
hence quantify the effect of the closed infusion
container. Admissions started in the susceptible state.
After a variable period of time, they either moved
straight to the discharged or dead states, or moved to
these states after becoming infected. Using the termi-
nology of state-space models, discharge and death are
absorbing states, and CLABSI is a transient state.
3 In
ﬁgure 1 the arrows are the transitions, and in this model
there are ﬁve possible transitions (disregarding the entry
transition). The advantage of a state-space model is that
CLABSI is correctly treated as a time-dependent cova-
riate,
4 and we can allow the effects of covariates to change
depending on what state the patient is in. Methods that
do not correctly classify patient’s risks and exposures in
time will bias conclusions. Time bias has been shown to
always overstate estimates of excess stay and death risk
from nosocomial infection.
5 Barnett et al illustrate the
effect of time bias on extra stay and death risk from
nosocomial infection.
6 The dates of the patient’s entry,
CLABSI infection and ﬁnal outcome were used to
calculate the times spent in each state. If the date of
a patient’s infection was the same as their date of
discharge or death, then we subtracted a half day from
the CLABSI date to ensure that they were recorded as
visiting the CLABSI state.
7 We followed the methods
described in Putter et al
8 to ﬁt the state-space model,
using the ‘clock reset’ approach and semi-Markov strat-
iﬁed hazards. When this method is used, the effect of
a covariate depends on the transition. For example,
older age may decrease the risk of a patient moving from
the ‘susceptible’ to ‘discharged’ states but increase their
risk of moving from the ‘susceptible’ to ‘dead’ states. We
ﬁtted the models using Cox proportional hazards, using
the R statistical package (http://www.r-project.org/),
which gives the hazard ratios (HRs) for the covariates.
The hazard is the rate at which admissions move from
one state to another. The HR describes the relative
change in this rate due to a change in the covariate. HRs
of 1 indicate no change in risk, HRs >1 indicate an
increased risk, and HRs <1 indicate a reduced risk. CIs
and p values for the HRs are shown.
The intervention of interest was the implementation
of the closed versus open infusion system (binary cova-
riate). We adjusted for the continuous covariates of age
and ASIS. Older age and higher ASIS are both likely to
increase the risk of death and decrease the risk of
discharge.
After estimating the changes in risks due to the closed
system, we calculated the number of admissions in each
state in ﬁgure 1 using a simulation study. For the open
and closed infusion container we started 1000 admis-
sions in the susceptible state and then followed their
movements and times spent in each state until discharge
or death. The transition rates were based on the esti-
mates from the Cox proportional hazards models. We
incorporated the uncertainty in these rates by allowing
the log-hazard rate to have a normal distribution based
on the estimated mean and SE. We simulated each set of
admissions 5000 times to cover the range of uncertainty.
For each simulation, we calculated the differences
between the systems in terms of bed days used, admis-
sions infected and admissions dying. We summarised
these differences using the mean and 95% Bayesian
credible interval over all 5000 simulations. These simu-
lations were carried out using differential equations in
the WBDiff add-on package to WinBUGS.
9
Figure 1 Four-state transition model to model length of stay
in an intensive care unit.
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Reducing line associated blood stream infectionsFor the descriptive statistics of the study sample, we use
the mean and SD for continuous variables that were
roughly normally distributed, and the median and IQR
otherwise.
RESULTS
Four admissions were excluded because it was not
recorded whether they died or were discharged. The
characteristics of the remaining admissions are shown in
table 1.
There were 2531 ICU admissions where a central line
was used at some time, and these admissions spent
25177 days in the ICU. The rate of CLABSIs was highest
in Mexico at 14.4 infections per 1000 admissions. The
HRs for age, ASIS score and the closed versus open
infusion container are shown in table 2.
In Mexico, older admissions were at less risk of
becoming infected with a CLABSI (HR 0.87, 95% CI 0.81
to 0.95, p¼0.001). In both cities, a higher ASIS score
strongly reduced the risk of moving from ‘susceptible’ to
‘discharged’, and so increased length of stay (p values
#0.001). In Mexico, a higher ASIS score increased the
risk of death. Sicker admissions with a CLABSI had
a lower chance of discharge compared with healthier
infected admissions, as the HR for moving from
‘CLABSI’ to ‘discharged’ was between 0.54 and 0.76 for
every one unit increase in ASIS score.
The closed infusion container strongly reduced the
risk of CLABSI in both cities (p values <0.001). The HR
of susceptible admissions becoming infected with
a CLABSI was between 0.15 and 0.31. In Mexico City and
Sa ˜o Paulo, the closed infusion container signiﬁcantly
increased the hazard of moving from ‘susceptible’ to
‘discharged’, meaning that admissions tended to
leave the ICU faster after its introduction. In Mexico,
the closed infusion container signiﬁcantly increased the
Table 1 Descriptive statistics by city for admissions with a central line
Mexico Sa ˜o Paulo
Dates June 2002eDecember 2003 October 2003eApril 2005
Number of ICU wards 4 3
Total number of admissions 1571 960
Patient days in ICU 12651 12526
Age (years), mean (SD) 53 (18.6) 54 (18.6)
ASIS, mean (SD) 3.7 (0.97) 3.8 (0.83)
Dead, n (%) 353 (22) 221 (23)
Admissions with a CLABSI, n (%) 168 (10.7) 69 (7.2)
CLABSIs per 1000 central line days 14.4 5.9
Central line days 11667 11695
Length of stay (days), median (IQR) 6 (4e10) 6 (4e12)
Admissions with a closed system, n (%) 535 (33.9) 418 (47.8)
ASIS, acute severity illness score; CLABSI, central line associated blood stream infection; ICU, intensive care unit.
Table 2 Hazard ratios and 95% CIs for rates of transmissions by city
Covariate Mexico Sa ˜o Paulo
Transition HR (95% CI) p Value HR (95% CI) p Value
Age (10 years)
Susceptible/CLABSI 0.87 (0.81 to 0.95) 0.001 1.03 (0.91 to 1.16) 0.67
Susceptible/Discharged 0.98 (0.95 to 1.01) 0.13 0.99 (0.95 to 1.03) 0.62
Susceptible/Dead 1.01 (0.94 to 1.07) 0.86 0.99 (0.92 to 1.06) 0.74
CLABSI/Discharged 1.03 (0.92 to 1.15) 0.64 0.96 (0.84 to 1.09) 0.55
CLABSI/Dead 1.01 (0.89 to 1.14) 0.90 1.12 (0.87 to 1.44) 0.39
ASIS score
Susceptible/CLABSI 1.07 (0.89 to 1.28) 0.47 0.86 (0.60 to 1.23) 0.40
Susceptible/Discharged 0.48 (0.45 to 0.51) <0.001 0.64 (0.58 to 0.71) <0.001
Susceptible/Dead 2.01 (1.70 to 2.38) <0.001 0.98 (0.79 to 1.20) 0.81
CLABSI/Discharged 0.54 (0.41 to 0.70) <0.001 0.76 (0.47 to 1.23) 0.27
CLABSI/Dead 0.94 (0.70 to 1.26) 0.66 1.33 (0.62 to 2.87) 0.47
Closed versus open system
Susceptible/CLABSI 0.15 (0.08 to 0.26) <0.001 0.31 (0.16 to 0.60) <0.001
Susceptible/Discharged 1.24 (1.10 to 1.40) <0.001 1.53 (1.31 to 1.78) <0.001
Susceptible/Dead 0.65 (0.50 to 0.84) <0.001 0.83 (0.61 to 1.11) 0.20
CLABSI/Discharged 2.56 (1.28 to 5.12) 0.008 1.70 (0.74 to 3.91) 0.21
CLABSI/Dead 0.77 (0.24 to 2.51) 0.67 1.88 (0.46 to 7.67) 0.38
ASIS, acute severity of illness score; CLABSI, central line associated blood stream infection.
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Reducing line associated blood stream infectionsrate of discharge for infected admissions (HR 2.56,
95% CI 1.28 to 5.12, p¼0.008), whereas there was
a non-signiﬁcant increase in this rate in Sa ˜o Paulo. In
Mexico, the closed infusion system reduced the risk of
death prior to infection (HR 0.65, 95% CI 0.50 to 0.84,
p<0.001).
Based on simulation results, the differences between
the closed and open infusion systems in terms of the
numbers of admissions infected with a CLABSI, deaths
and total number of bed days, are shown in table 3.
In both cities the number of infected admissions with
a CLABSI was signiﬁcantly less with the closed infusion
container. The reduction in the number of infections
was largest in Mexico (120 less infected admissions per
1000 admissions with a central line), which reﬂects the
fact that it showed the largest reduction in hazard under
the closed infusion container system (table 2). The
closed infusion container also resulted in fewer deaths
and in both cities this reduction was statistically signiﬁ-
cant. In Mexico there was very little change in the
number of bed days, but in Sa ˜o Paulo there was a big
reduction of 2693 bed days per 1000 admissions with
a central line.
Thenumber of admissionsovertime ineach ofthe four
states(basedonthe simulations)is shown inﬁgure 2.The
lines show the mean numbers in each state during the
ﬁrst 60 days. The reduction in CLABSI rates due the
closed infusion container can be seen in the 0 to 20-day
period and are shown on the graph as fewer individuals
having a CLABSI. Because of this outcome, more patients
are being discharged and there are fewer deaths;
these outcomes are also shown by the lines in ﬁgure 2.
DISCUSSION
From a clinician’s perspective, the closed system might
be superior to using semi-rigid glass or plastic bottles
that are externally vented to allow the ﬂuid to leave.
These open systems were thought to be responsible for
a large outbreak of gram-negative bacteraemia
10 and
smaller outbreaks
11 from contaminated infusate. Other
beneﬁts for clinicians are less breakage, reduced weight,
easier disposal and greater durability.
12
A decision to adopt closed infusion containers is
supported by the evidence revealed here of reduced
rates of CLABSI in both cities. After adoption, the HR of
susceptible admissions becoming infected with a CLABSI
was 0.15 in Mexico City and 0.31 in Sa ˜o Paulo. This
represents a reduction in risk of between three- and
sevenfold. A higher ASIS score inﬂuenced risk in an
intuitive way, by reducing the risk of discharge and
increasing the risk of death. The results of the simulated
data conﬁrmed that the closed infusion container
resulted in a clinically and statistically signiﬁcant reduc-
tion in the number of CLABSIs. Based on 1000 admis-
sions with a central line, we expect 120 less CLABSIs in
Mexico and 64 less in Sa ˜o Paulo, a reduced number of
deaths and in Sa ˜o Paulo a signiﬁcant saving in bed days.
These ﬁndings are intuitive and easy to interpret for
policy making. There are fewer infections and fewer
deaths. There will also be cash savings from avoided
consumables used to treat the infection. These savings
must be balanced against the higher economic costs of
implementing the closed infusion container system. All
the other costs of running an ICU, such as staff time,
capital equipment and buildings, and clinical and
indirect overheads, will remain ﬁxed regardless of the
rate of CLABSI and so no other ﬁnancial costs will
change in the short term.
A major economic beneﬁt of fewer infections is that
bed days are released for other uses. These bed days will
have a positive economic value if demand for ICU
services exceeds supply.
13 14 Their value depends on the
preferences of decision makers who allocate scarce
healthcare expenditures in each setting. If, for example,
decision makers in Sa ˜o Paulo are willing to pay $300 to
access a marginal ICU bed day,
15 then the economic
value of the cost savings for the 1000 simulated admis-
sions under a closed infusion container system is
$807900. These can be thought of as economic savings
Table 3 Difference in the number of infected and dead admissions, and the difference in total bed days for the open and
closed systems based on 1000 simulated admissions with a central line
Mexico Sa ˜o Paulo
Mean (95% CI) Mean (95% CI)
Numbers infected
Open system 146 (76 to 266) 92 (37 to 182)
Closed system 26 (9 to 61) 28 (8 to 73)
Difference* 120 (62 to 213) 64 (24 to 129)
Numbers dead
Open system 251 (102 to 395) 267 (125 to 407)
Closed system 161 (47 to 294) 187 (74 to 322)
Difference* 90 (27 to 158) 81 (25 to 143)
Bed days
Difference* 34 (e1211 to 1246) 2693 (1152 to 4569)
Simulated for admissions of an average age and ASIS score.
*Open minus closed.
CI, credible interval.
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Reducing line associated blood stream infectionsto offset the costs of adoption. With higher ICU
throughput, there will of course be increased variable
costs from treating new admissions.
10 11 In addition to
changes in costs, there will be large health beneﬁts from
fewer deaths. The average age of the Sa ˜o Paulo cohort
was 54 years (table 1); if an extra 18 years of life results
from an avoided death, then 1458 years of life will be
gained.
A complete economic analysis would consider the full
implementation costs of a closed system, how much
these are offset by cost savings from reduced infections,
and the extra quality adjusted life years gained. This
analysis does not show all these outcomes. However,
ﬁndings do support the idea that CLABSI increases risk
of death and is costly as it prolongs length of hospital
stay. A decision to adopt the closed infusion container in
Figure 2 Numbers in each state over the ﬁrst 60 days in an intensive care unit (ICU) in two cities based on 1000 simulated
admissions with a central line. CLABSI, central line associated blood stream infection.
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Reducing line associated blood stream infectionsMexico and Sa ˜o Paulo could potentially reduce costs and
generate health beneﬁts.
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